Pharmacorp Rx Inc. (TSE:PCRX) has released an update.
PharmaCorp Rx Inc. has announced the filing of its Q3 2024 financial statements, highlighting its strategic expansion in the Canadian pharmacy market. The company operates three pharmacies under the PharmaChoice banner and plans to continue acquiring both PharmaChoice and independent pharmacies across Canada.
For further insights into TSE:PCRX stock, check out TipRanks’ Stock Analysis page.